Skip to main content
. Author manuscript; available in PMC: 2021 Aug 2.
Published in final edited form as: Oncogene. 2021 Feb 2;40(9):1690–1705. doi: 10.1038/s41388-021-01658-z

Fig 6. High ULK1 tumor expression predicts poor patient prognosis in independent clinical cohorts of men with prostate cancer.

Fig 6.

Kaplan-Meier estimates of disease-free survival in The Cancer Genome Atlas (TCGA) and Taylor et al. 2010 clinical cohorts based on ULK1 expression. Data were generated from cBioPortal. The high expression ULK1 group was defined by ULK1 mRNA expression > 2 SD above the mean.